Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry

Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry

Background Ticagrelor reduces ischaemic end points in acute coronary syndromes. However, outcomes of ticagrelor versus clopidogrel in real‐world patients with acute coronary syndromes treated with percutaneous coronary intervention (PCI) remain unclear. We sought to examine whether treatment with ti...

Full description

Bibliographic Details
Main Authors: Sebastian Völz, Petur Petursson, Jacob Odenstedt, Dan Ioanes, Inger Haraldsson, Oskar Angerås, Christian Dworeck, Geir Hirlekar, Anna Myredal, Per Albertsson, Truls Råmunddal, Björn Redfors, Elmir Omerovic
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
clopidogrel
non‐ST‒segment‐elevation myocardial infarction
ST‐segment‒elevation myocardial infarction
P2Y12 receptor antagonists
percutaneous coronary intervention
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.015990

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.015990

Similar Items